Journal of Obstetrics and Gynaecology Research最新文献

筛选
英文 中文
Phenotypes and clinical laboratory data for polycystic ovary syndrome cases: A nationwide survey in Japan 多囊卵巢综合征病例的表型和临床实验室数据:日本全国性调查。
IF 1.6 4区 医学
Journal of Obstetrics and Gynaecology Research Pub Date : 2024-10-30 DOI: 10.1111/jog.16136
Hiroki Noguchi, Takeshi Iwasa, Akira Iwase, Haruhiko Kanasaki, Fuminori Kimura, Koji Kugu, Kazuki Saito, Tsuyoshi Baba, Tetsuaki Hara, Toshiya Matsuzaki
{"title":"Phenotypes and clinical laboratory data for polycystic ovary syndrome cases: A nationwide survey in Japan","authors":"Hiroki Noguchi,&nbsp;Takeshi Iwasa,&nbsp;Akira Iwase,&nbsp;Haruhiko Kanasaki,&nbsp;Fuminori Kimura,&nbsp;Koji Kugu,&nbsp;Kazuki Saito,&nbsp;Tsuyoshi Baba,&nbsp;Tetsuaki Hara,&nbsp;Toshiya Matsuzaki","doi":"10.1111/jog.16136","DOIUrl":"10.1111/jog.16136","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>Describe the current phenotypes and clinical laboratory data regarding polycystic ovary syndrome (PCOS) in Japan, taking into account ethnic differences and obesity status.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Data for 986 PCOS cases and 965 control cases were collected using a nationwide survey in Japan. Obese/overweight (body mass index [BMI] ≥25 kg/m<sup>2</sup>) and non-obese/overweight (BMI &lt;25 kg/m<sup>2</sup>) cases were compared.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Japanese PCOS cases predominantly involved non-obese/overweight patients, accounting for 75% of all cases. Among non-obese/overweight PCOS cases, the incidence of both amenorrhea and clinical/biochemical hyperandrogenism was significantly lower than in obese/overweight PCOS cases, whereas the rate of elevated serum luteinizing hormone (LH) level was significantly higher. Even though the incidence of hirsutism in Japan is only 13.5%, the detection rate for hyperandrogenism increased by as much as 30.4% when hirsutism was added to the Japan Society of Obstetrics and Gynecology (JSOG) criteria for the diagnosis of hyperandrogenism in addition to elevated serum total testosterone level. When evaluated based on timing of blood sampling, the LH level and LH/follicle-stimulating hormone ratio determined at the initial consultation involving a chief complaint of irregular menstrual cycle (after confirming the absence of follicles measuring ≥1 cm in diameter) were significantly higher than on days 2–3 or 4–6 of the menstrual cycle.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Ethnic differences, including obesity status, affected the phenotype and clinical laboratory data of Japanese PCOS patients, such as the incidence rates of clinical/biochemical hyperandrogenism and the rate of elevated basal LH level. Adding hirsutism to the JSOG 2024 criteria would enhance the accuracy of PCOS diagnosis and enhance consistency with the Rotterdam 2003 criteria. Measuring basal LH level is useful for assessing the endocrinologic characteristics of Japanese PCOS cases, as well as lean Asian PCOS cases, but the timing of blood sampling can affect the result.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"50 12","pages":"2346-2356"},"PeriodicalIF":1.6,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Golden Jubilee 50th volume of the Journal of Obstetrics and Gynecology Research 妇产科研究杂志》金禧 50 卷。
IF 1.6 4区 医学
Journal of Obstetrics and Gynaecology Research Pub Date : 2024-10-29 DOI: 10.1111/jog.16029
Rohana Haththotuwa
{"title":"Golden Jubilee 50th volume of the Journal of Obstetrics and Gynecology Research","authors":"Rohana Haththotuwa","doi":"10.1111/jog.16029","DOIUrl":"10.1111/jog.16029","url":null,"abstract":"","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"50 S1","pages":"9-14"},"PeriodicalIF":1.6,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Navigating the landscape of cervical cancer in India: Epidemiology, prevention, current status, and emerging solutions 了解印度宫颈癌的现状:流行病学、预防、现状和新兴解决方案。
IF 1.6 4区 医学
Journal of Obstetrics and Gynaecology Research Pub Date : 2024-10-29 DOI: 10.1111/jog.16030
Krishnendu Gupta, Ranajit Mandal, Puja Chatterjee
{"title":"Navigating the landscape of cervical cancer in India: Epidemiology, prevention, current status, and emerging solutions","authors":"Krishnendu Gupta,&nbsp;Ranajit Mandal,&nbsp;Puja Chatterjee","doi":"10.1111/jog.16030","DOIUrl":"10.1111/jog.16030","url":null,"abstract":"<p>Cervical cancer poses a significant health burden for women worldwide, particularly in India. Despite global progress, India's mortality rate, with 79 906 deaths, remains disproportionately high at approximately 11.2 per 100 000 women compared to the global average of 7.1 per 100 000 women. India's NPCDCS and other initiatives focus on VIA screening for women aged 30–65. The National Health Policy 2017 emphasizes primary healthcare enhancement, allocating two-thirds of the budget. Ayushman Bharat promotes universal health coverage, including Health and Wellness Centers and PM-JAY. Initiatives like Ayushman Bharat and the National Cancer Grid offer hope for improved cancer care. Leveraging technology, strengthening infrastructure, integrating services, promoting awareness, and enhancing HPV vaccination are crucial. By addressing barriers, improving access, and fostering collaboration, the cervical cancer burden can be reduced, ensuring better health outcomes for women nationwide.</p>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"50 S1","pages":"55-64"},"PeriodicalIF":1.6,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The AOFOG recommendations on human papillomavirus vaccination in the Asia-Pacific region AOFOG 关于亚太地区人类乳头瘤病毒疫苗接种的建议。
IF 1.6 4区 医学
Journal of Obstetrics and Gynaecology Research Pub Date : 2024-10-29 DOI: 10.1111/jog.16034
Ka Yu Tse, Ai Ling Tan, Kirtipal Subedi, Shahana Pervin, Krishnendu Gupta, Brahmana Askandar Tjokroprawiro, Yin Ling Woo, Sarikapan Wilailak, Kazunori Ochiai, Pisake Lumbiganon, Christia Padolina
{"title":"The AOFOG recommendations on human papillomavirus vaccination in the Asia-Pacific region","authors":"Ka Yu Tse,&nbsp;Ai Ling Tan,&nbsp;Kirtipal Subedi,&nbsp;Shahana Pervin,&nbsp;Krishnendu Gupta,&nbsp;Brahmana Askandar Tjokroprawiro,&nbsp;Yin Ling Woo,&nbsp;Sarikapan Wilailak,&nbsp;Kazunori Ochiai,&nbsp;Pisake Lumbiganon,&nbsp;Christia Padolina","doi":"10.1111/jog.16034","DOIUrl":"10.1111/jog.16034","url":null,"abstract":"<p>Cervical cancer remains a disease burden in Asia. The Asia and Oceania Federation of Obstetrics and Gynecology envisages a need to produce a set of recommendations on the implementation of human papilloma virus vaccination program for both lower-middle-income countries (LMICs) and high-income countries (HICs), with an attempt to harmonize the practices yet allow flexibility to cater for different cultures, religions, needs and background of individual countries/cities. International guidelines and literature were sought, and recommendations were made in seven selected areas, including (i) the target groups for vaccination, (ii) the doses of vaccination including the use of single-dose vaccination, (iii) the types of vaccines, (iv) suggestions for special populations including those with previous HPV infection, human immunodeficiency virus carriers, and lesbian, gay, bisexual, transgender, questioning/queer group, (v) inter-changeability and the need of revaccination/booster, (vi) novel technologies and vaccines, and (vii) public education.</p>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"50 S1","pages":"95-102"},"PeriodicalIF":1.6,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jog.16034","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Celebrating JOGR's 50th volume of publication 庆祝《日本期刊》第 50 卷出版。
IF 1.6 4区 医学
Journal of Obstetrics and Gynaecology Research Pub Date : 2024-10-29 DOI: 10.1111/jog.16002
Hiroaki Kajiyama
{"title":"Celebrating JOGR's 50th volume of publication","authors":"Hiroaki Kajiyama","doi":"10.1111/jog.16002","DOIUrl":"10.1111/jog.16002","url":null,"abstract":"","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"50 S1","pages":"5-6"},"PeriodicalIF":1.6,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asia Oceania Federation of Obstetrics and Gynecology (AOFOG)'s efforts in the cervical cancer elimination program in the Asia-Pacific 亚洲大洋洲妇产科联合会(AOFOG)在亚太地区消除宫颈癌计划中所做的努力。
IF 1.6 4区 医学
Journal of Obstetrics and Gynaecology Research Pub Date : 2024-10-29 DOI: 10.1111/jog.16032
Christia S. Padolina, Jean Anne B. Toral
{"title":"Asia Oceania Federation of Obstetrics and Gynecology (AOFOG)'s efforts in the cervical cancer elimination program in the Asia-Pacific","authors":"Christia S. Padolina,&nbsp;Jean Anne B. Toral","doi":"10.1111/jog.16032","DOIUrl":"10.1111/jog.16032","url":null,"abstract":"<p>Cervical cancer poses a significant health burden, particularly in low- and middle-income countries, where access to screening and treatment remains limited. Asia Oceania Federation of Obstetrics and Gynecology (AOFOG)'s response, guided by the World Health Organization's global strategy, emphasizes three key targets: achieving high HPV vaccination coverage among girls, ensuring widespread screening with high-performance tests, and guaranteeing timely treatment for precancerous and cancerous lesions. AOFOG supports member countries through initiatives such as educational campaigns, guidelines development, and collaboration with local and international partners. Variations in screening methods across AOFOG member countries reflect diverse socioeconomic contexts and healthcare infrastructures, ranging from HPV testing in countries like Australia and Malaysia to cytology and visual inspection methods in others. Innovations such as HPV self-testing and AI-enhanced screening are emerging to improve accessibility and accuracy, addressing barriers like stigma and resource scarcity. Despite challenges, AOFOG remains committed to reducing cervical cancer incidence and mortality through coordinated regional efforts, aiming for equitable access to preventive measures and treatment across the diverse landscape of the Asia-Pacific region.</p>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"50 S1","pages":"42-48"},"PeriodicalIF":1.6,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Congratulations Golden Jubilee volume of JOGR—Memory of VIA (very important assignment) 祝贺《日刊》金禧纪念卷--《VIA 的记忆》(非常重要的任务)。
IF 1.6 4区 医学
Journal of Obstetrics and Gynaecology Research Pub Date : 2024-10-29 DOI: 10.1111/jog.16021
Kazunori Ochiai
{"title":"Congratulations Golden Jubilee volume of JOGR—Memory of VIA (very important assignment)","authors":"Kazunori Ochiai","doi":"10.1111/jog.16021","DOIUrl":"10.1111/jog.16021","url":null,"abstract":"","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"50 S1","pages":"23-24"},"PeriodicalIF":1.6,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Latest findings in chemotherapy 化疗方面的最新研究成果。
IF 1.6 4区 医学
Journal of Obstetrics and Gynaecology Research Pub Date : 2024-10-29 DOI: 10.1111/jog.16028
Tohru Morisada
{"title":"Latest findings in chemotherapy","authors":"Tohru Morisada","doi":"10.1111/jog.16028","DOIUrl":"10.1111/jog.16028","url":null,"abstract":"<p>Radiotherapy and surgery are the two pivotal curative treatments for cervical cancer. Although cervical cancer is relatively sensitive to chemotherapy, chemotherapy is not included in the curative treatment of cervical cancer and has a role in limited medical conditions. Chemotherapy used to treat cervical cancer can be divided into four categories: (1) preceding chemotherapy (neoadjuvant chemotherapy) to augment the effects of radical therapy (surgery or radiation therapy), (2) chemotherapy administered concurrently with radiation therapy, and (3) adjuvant chemotherapy administered after radical therapy. In addition, (4) chemotherapy is used to prolong survival and alleviate symptoms in patients who cannot be radically cured. Recently, molecular targeted agents, angiogenesis inhibitors, and immune checkpoint inhibitors have been incorporated into existing chemotherapy regimens. This review summarizes these trends along with the history of chemotherapy for cervical cancer.</p>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"50 S1","pages":"79-83"},"PeriodicalIF":1.6,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends of minimally invasive surgery in the primary treatment of cervical cancer 微创手术在宫颈癌初级治疗中的发展趋势。
IF 1.6 4区 医学
Journal of Obstetrics and Gynaecology Research Pub Date : 2024-10-29 DOI: 10.1111/jog.16075
Tsukasa Baba
{"title":"Trends of minimally invasive surgery in the primary treatment of cervical cancer","authors":"Tsukasa Baba","doi":"10.1111/jog.16075","DOIUrl":"10.1111/jog.16075","url":null,"abstract":"<p>Minimally invasive surgery (MIS), including laparoscopic and robot-assisted procedures, has rapidly advanced in the treatment of gynecologic malignancies worldwide. However, its adoption and insurance coverage in AOFOG countries remain limited, particularly for advanced uterine and ovarian cancers. This limitation poses a challenge to the widespread use of MIS, highlighting the need for a more comprehensive evaluation of its role and the skills required by gynecologic oncologists to ensure safe and effective treatment. Furthermore, the Laparoscopic Approach to Cervical Cancer trial significantly impacted perceptions of MIS, revealing higher recurrence rates and inferior overall survival for minimally invasive radical hysterectomy (MIS-RH) compared to abdominal radical hysterectomy. Subsequent studies confirmed these findings, raising questions about the suitability of MIS-RH, particularly in centers with limited experience. Key issues affecting MIS outcomes include surgical expertise and tumor spillage prevention. As the landscape of cervical cancer treatment evolves, the integration of radiotherapy, chemotherapy, and immune therapies has challenged the traditional reliance on surgical monotherapy. There also exists ongoing debate over the optimal use of MIS in primary treatment and salvage surgery for cervical cancer to refine MIS techniques and explore their role in preserving fertility and managing residual disease post-chemoradiotherapy. For ensuring MIS as a viable treatment option, it is continuously necessary accumulating real-world data and reassessing surgical strategies to balance efficacy, safety, and patient preferences.</p>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"50 S1","pages":"72-78"},"PeriodicalIF":1.6,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Celebrating the 50 years of excellence in women's health: The 50th anniversary of The Journal of Obstetrics and Gynecology Research 庆祝妇女健康领域 50 年的卓越成就:妇产科研究杂志》创刊 50 周年。
IF 1.6 4区 医学
Journal of Obstetrics and Gynaecology Research Pub Date : 2024-10-29 DOI: 10.1111/jog.16048
Tsung-Hsien Su
{"title":"Celebrating the 50 years of excellence in women's health: The 50th anniversary of The Journal of Obstetrics and Gynecology Research","authors":"Tsung-Hsien Su","doi":"10.1111/jog.16048","DOIUrl":"10.1111/jog.16048","url":null,"abstract":"","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"50 S1","pages":"15-16"},"PeriodicalIF":1.6,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信